InphA participated in the WHO Conference “Consultation on Quality Control and Pharmaceutical Specifications of Medicines” from 25 – 27 April in Geneva.
Dr. Frank Höper presented laboratory results from the verifications of the draft monographs Molnupiravir active pharmaceutical ingredient and capsules and Nirmatrelvir active pharmaceutical ingredient and tablets. The monographs mentioned are to be included in the WHO International Pharmacopoeia.
